People channel feed

Ivan Che­ung's post-Ei­sai life takes hold at Next­Point Ther­a­peu­tics; Sanofi, Take­da an­nounce CFO ex­its

Last year
Peer Review

Up­dat­ed: Law­suit ac­cus­es UPenn and Jim Wil­son of se­cret­ly prof­it­ing from for­mer post­doc's work

Last year
Law

No­vavax an­nounces an­oth­er round of lay­offs, lets go 12% of em­ploy­ees

Last year
Coronavirus

The aca­d­e­m­ic-en­tre­pre­neur mod­el built com­pa­nies and mint­ed mil­lion­aires. What hap­pens when one of its ear­li­est ad­vo­cates quits?  

Last year
Startups
In Focus

CAR NK biotech Cata­ma­ran Bio to wind down, will seek part­ners for cell ther­a­pies

Last year
Cell/Gene Tx

Ex­it in­ter­view: FDA leg­end Janet Wood­cock­'s thoughts on the agency and its con­tro­ver­sies

Last year
FDA+

Roche ends KRAS deal with Hookipa Phar­ma, as biotech lays off 30% of staff

Last year
Deals
R&D

In­no­va­tion En­deav­ors’ Joel Dud­ley on grow­ing in­ter­est in life sci­ences with new fund — and why he hates ‘tech­bio’

Last year
Financing

Bay­er’s ra­di­ol­o­gy head plans re­tire­ment; Ex-Sanofi chief Olivi­er Brandi­court joins BeiGene’s board

Last year
Peer Review

Ex­clu­sive: Strand lays off 18% of staff as its first mR­NA ther­a­pies head in­to the clin­ic

Last year
R&D

Ex­clu­sive: Teladoc makes job cuts, elim­i­nates some roles in en­gi­neer­ing and da­ta sci­ence

Last year
Health Tech

In bid to ex­tend cash run­way, Cara to lay off work­ers, dis­con­tin­ue PhI­II pro­gram in chron­ic kid­ney dis­ease

Last year
Pharma

Ap­n­imed hires Pfiz­er, Bio­haven vet­er­an as chief com­mer­cial of­fi­cer

Last year
Pharma
Marketing

For­mer Ther­a­nos CEO Eliz­a­beth Holmes is banned from fed­er­al health pro­grams for al­most a cen­tu­ry

Last year

Af­ter Bris­tol My­ers pulls out of col­lab­o­ra­tion, Ike­na On­col­o­gy lays off 35% of staff and trims can­cer pipeline

Last year
R&D

Neu­ro­science leg­end Steve Paul re­tires; Ex­clu­sive: GSK hires ex-In­nate Phar­ma CEO for new po­si­tion

Last year
Peer Review

'Peo­ple want vanil­la ice cream': CEO Anne Wo­j­ci­c­ki grap­ples with 23and­Me's dual iden­ti­ty

Last year
Pharma

Dew­point Ther­a­peu­tics re­struc­tures to ‘make room’ for en­try in­to the clin­ic next year in on­col­o­gy, ALS

Last year
Startups

As­traZeneca reshuf­fles Chi­na lead­er­ship, sets up bio­phar­ma group to mir­ror glob­al struc­ture

Last year
China
Pharma

Reagent mak­er Al­pha Tekno­va cuts 15% of work­ers, ter­mi­nates com­mer­cial, peo­ple ex­ec roles amid down­turn

Last year
Manufacturing

Lon­za to shut­ter Cal­i­for­nia mam­malian clin­i­cal fa­cil­i­ty and lay off 218 staffers

Last year
Manufacturing

Al­lakos halves work­force, drops lead in­flam­ma­to­ry pro­gram

Last year
R&D

Up­dat­ed: Vivek Ra­maswamy gives up pres­i­den­tial bid, en­dors­es Trump, no plans to re­turn to Roivant

Last year

Bio­Mar­in's chief com­mer­cial of­fi­cer step­ping down, search for suc­ces­sor be­gins

Last year
Pharma
First page Previous page 14151617181920 Next page Last page
A service from the Financial Times